Developments in cancer prevention and treatment using traditional Chinese medicine

Frontiers of Medicine in China

Volumn 5, Issue 2, 2011, Pages 127-133

  Lin, Hongsheng ^a   Liu, Jie ^a   Zhang, Ying ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Cancer; Traditional Chinese medicine (TCM)

Indexed keywords

CANCER PREVENTION; CANCER THERAPY; CHINESE MEDICINE; CLINICAL RESEARCH; HUMAN; JOINT; ONCOLOGY; PHYSICIAN;

EID: 82355165064     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-011-0137-7     Document Type: Review

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr
2. Han YY, Feng P, Wen ZhY. Research development on Chinese herbs of anticancer. J Beijing TCM (Beijing Zhong Yi) 2003; (2): 45-48 (in Chinese)
3. Gao WB. Research development on Chinese herbs of anticancer. Med J Liaoning (Liaoning Yi Yao) 1977; (6): 29-33 (in Chinese)
4. Tian JZh. Pharmacological classification and clinical significance of anti-cancer Chinese herbs. J Shandong College Tradit Chin Med (Shandong Zhong Yi Xue Yuan Xue Bao) 1986; 10(2): 16-19 (in Chinese)
5. Tang MX, Yu GQ, Duan FW. An antitumorigenic study by a TCM formula belonging to the category of enhancing the righteousness and consolidating the foundation. Chin J Cancer (Ai Zheng) 1986; 5(1): 65-69 (in Chinese)
6. Zhang DZh, Xu JD, Li PW, Dong XR, Hao YX, Li X, Cai GR, Cui HJ, Wan DG, Zhou W, Yu GQ. Clinical and experimental researches on improving radiation sensibility for lung cancer patients by "Fu Zheng Zeng Xiao"(FZ). Chin J Surg of Integr Tradit West Med (Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi) 1998; 4(2): 71-75 (in Chinese)
7. Liu JX, Xu ZY, Shi ZM, Guo YH, Fan Zh Z, Li MH, Huang JM, Zhu YW, Zhao LH, Shi ChM, Gao H, Chen SX. Prospective study on Fuzheng treatment in 122 advanced non-small cell lung cancer patients. China J Tradit Chin Med Pharm(Zhongguo Yi Yao Xue Bao) 1987; 2(1): 12-16 (in Chinese)
8. Pan MJ, Li YH, Chen LF. Observation of the long term curative effect of 150 cases of nasopharyngeal cancer treated with Fu Zheng Sheng Jin decoction and radiotherapy. J Integr Tradit West Med (Zhong Xi Yi Jie He Za Zhi) 1985; 5(2): 83-85 (in Chinese)
9. Cai WM, Hu YH, Zhang HX, Xu GZh, Qin DX, Wu XL, Yan JH, Gu XZh. Prospective controlled trial of nasopharyngeal carcinoma treated with traditional Chinese medicine and radiation therapy. J Tradit Chin Med (Zhong Yi Za Zhi) 1983; (9): 36-38 (in Chinese)
10. Zhang DZh. Integrated traditional Chinese medicine and western medicine in advanced lung cancer. J China-Japan Friendship Hosp (Zhong Ri You Hao Yi Yuan Xue Bao) 1987; 1(1): 33-37 (in Chinese)
11. Liu LM, Lin ShY, Wu LC, Wang ZS, Zhou WSh, Guo Y, Shen MH, Yang WH. Xie ChSh. Clinical observation on the synergic and detoxified action of injection of Radix Codonopsis and Radix Ophiopogonis in chemotherapy of lung cancer. J Tradit Chin Med (Zhong Yi Za Zhi)1994; 35(5): 280-282 (in Chinese)
12. Sun GZh, Wang GM, Chen ChH, Song L, Zhang PT, Pan XM, Hou W, Zhang PY, Yang ZY. YGQ. Clinical and experimental study on treatment of advanced gastrointestinal carcinoma with Fuzheng-Fangai oral liquid combined with chemotherapy. Chin J Surg of Integr Tradit West Med(Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi)1995; 1(5): 266-270 (in Chinese)
13. Fang XX, Wang ShH, Li LQ, Wang L. Observation of treatment with integrative medicine to reduce chemotherapy-induced leukocyte and platelet in 168 patients. J Clin Oncol (Lin Chuang Zhong Liu Xue Za Zhi) 1997; 2(3): 56 (in Chinese)
14. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, Wu Y, Song Y, Luo J, Pang X, Yi Z, Liu M. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis 2010; 31(12): 2097-2104
15. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Thé H, Chen SJ, Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010; 328(5975): 240-243
16. Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 2008; 68(11): 4347-4351
17. Chen X, Murakami T, Oppenheim JJ, Howard OM. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood 2005; 106(7): 2409-2416
18. Tsai CH, Lin FM, Yang YC, Lee MT, Cha TL, Wu GJ, Hsieh SC, Hsiao PW. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Clin Cancer Res 2009; 15(17): 5435-5444
19. Lin HS, Li ShQ, Piao BK. Effective evaluation methods for treatment with traditional Chinese medicine in advanced lung cancer. Bull Chin Cancer (Zhongguo Zhong Liu) 2000; 9(8): 354-355 (in Chinese)
20. Zhang PT, Yu MW, Yang ZY, Li DR, Liu YH, Lin HSh. Compared study on effective evaluation methods of TCM andWMin advanced non-small cell lung cancer. J Integr Tradit West Med(Zhong Xi Yi Jie He Za Zhi) 2010; 30(7): 702-705 (in Chinese)
21. Lin LZh, Lan ShQ, Zhou DH. A discussion on the criterion of therapeutical effect of malignant tumor(solid carcinoma) in TCM. New J Tradit Chin Med(Xin Zhong Yi) 2001; 33(8): 5-6(in Chinese)
22. Sun HY, Xing YM, Li YW, Liu DY, Xie GR. Quality evaluation of randomized controlled trails in Chinese medicine combined with chemotherapy in non-small cell lung cancer. 3rd International Congress of TCM and Integrated TCM-WM Oncology. 2010, 84-85 (in Chinese)
23. Lin HSh, Zhang Y. Evidence-based medical study of TCM on nonsmall cell lung cancer. World Sci Technol-Modernization Tradit Chin Med (Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua) 2008;(4): 121-125 (in Chinese)
24. Sun Y, Lin H, Zhu YZH, Feng JF, Chen ZhT, Li GS, Zhang XR, Zhang ZQ, Tang JF, Shi MQ, Hao XZH, Han H. A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine + cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients. Chin J Lung Cancer (Zhongguo Fei Ai Za Zhi) 2006; 9(3): 254-258 (in Chinese)
25. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology-Non-Small Cell Lung Cancer V.2. 2009. Available from: http://www.nccn.org
26. Zheng ChS, Chen LW, Huang Q, Hu J, Du J, Xu XJ. Establishment of computer simulation analysis for Multi-target anti-tumor effect of Chinese medicine. J Fujian College Tradit Chin Med (Fujian Zhong Yi Xue Yuan Xue Bao) 2007; 17(3): 37-40(in Chinese)
27. Wu Q, Bi ZhM, Li P, Qi LW. Advances in biological screeningchemical analysis of the bioactive components in traditional Chinese medicines based on holistic characteristics. J China Pharm Univ (Zhongguo Yao Ke Da Xue Xue Bao) 2007; 38(4): 289-293 (in Chinese)
28. Hao H, Cui N, Wang G, Xiang B, Liang Y, Xu X, Zhang H, Yang J, Zheng C, Wu L, Gong P, Wang W. Global detection and identification of non-target components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy. Anal Chem 2008; 80(21): 8187-8194
29. Zhou XZh, Liu BY, Yao NL, Chen SB, Li P, Wang YH, Zhang RSh. Studies and Applications: TCM Clinical Data Warehouse and Associated Data Mining Platform. World Sci Technol-Modernization Tradit Chin Med (Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua) 2007; 9(4): 74-80(in Chinese)
30. Liu J, Lin HSh, Hou W, Li DR, Zhou XZh. Pilot study on the characteristics of Chinese medicine treatment in lung cancer patients by use of data mining methods. World Sci Technol-Modernization Tradit Chin Med (Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua) 2009; 11(5): 753-757(in Chinese)
31. Investment Advisor in the Industry Research Center. 2010-2015 Investment Analysis of Chinese medicine industry and Forecast Report. 2010,5. Available from: http://www.con.com.cn
32. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22(12): 2489-2503
33. Gan T, Wu Z, Tian L, Wang Y. Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database Syst Rev 2010; (1): CD005096
34. Wei X, Chen Z, Yang X, Wu T. Chinese herbal medicines for esophageal cancer. Cochrane Database Syst Rev 2009; (4): CD004520
35. McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM Jr. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-smallcell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006; 24(3): 419-430